NRXP NRx Pharmaceuticals, Inc.
2.900USD-1.36%Mkt Cap: 125.56M $P/E: —1d ago
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), an…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap125.56M USD
Enterprise Value101.34M USD
Revenue (TTM)3.39M USD
Gross Profit720.00K USD
Net Income (TTM)-28.62M USD
Revenue/Share0.11 USD
Last Price2.900 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.40
PEG—
EV/EBITDA-5.13
EV/Revenue29.86
P/S37.50
P/B-735.00
EPS (TTM)-0.58
EPS (Forward)-0.35
52W Range
1.62037% of range5.055
52W High5.055 USD
52W Low1.620 USD
Profitability
Gross Margin58.78%
Oper. Margin-590.46%
EBITDA Margin0.00%
Profit Margin-2336.49%
ROE179.59%
ROA-220.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.11M USD
CapEx (TTM)—
FCF Margin-284.02%
FCF Yield-7.68%
Net Debt-25.85M USD
Net Debt/EBITDA1.31
Balance Sheet
Debt/Equity-0.04
Current Ratio0.86
Quick Ratio0.79
Book Value/Sh-0.0040 USD
Cash/Share0.62 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 2, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)38.50 USD
Upside (mean)+1227.6%
Target Range10.00 USD – 50.00 USD
10.00+1227.6% to mean50.00
# Analysts4
Ownership
Shares Out.43.30M
Float37.39M
Insiders4.12%
Institutions27.13%
Short Interest
Short Ratio13.8d
Short % Float23.54%
Short % Out.22.57%
Shares Short9.77M
Short (prev mo.)8.67M
Technical
SMA 503.309 (-12.4%)
SMA 2002.942 (-1.4%)
Beta2.07
S&P 52W Chg16.45%
Avg Vol (30d)674.82K
Avg Vol (10d)682.80K
Technical Indicators
RSI (14)36.1
MACD-0.1570
MACD Signal-0.1422
MACD Hist.-0.0148
BB Upper3.650 USD
BB Middle3.151 USD
BB Lower2.652 USD
BB Width31.70%
ATR (14)0.1681 USD
Vol Ratio (20d)0.63x